Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Intensified secondary prevention intending a reduction of recurrent events in TIA and minor stroke patients (INSPiRE-TMS): a protocol for a randomised controlled trial.

Leistner S, Michelson G, Laumeier I, Ahmadi M, Smyth M, Nieweler G, Doehner W, Sobesky J, Fiebach JB, Marx P, Busse O, Köhler F, Poppert H, Wimmer ML, Knoll T, Von Weitzel-Mudersbach P, Audebert HJ.

BMC Neurol. 2013 Jan 24;13:11. doi: 10.1186/1471-2377-13-11.

2.

Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack.

Li J, Liu J, Liu M, Zhang S, Hao Z, Zhang J, Zhang C.

Cochrane Database Syst Rev. 2015 Sep 8;(9):CD009938. doi: 10.1002/14651858.CD009938.pub2. Review.

PMID:
26346232
3.
4.

Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attack.

Liu J, Wang LN.

Cochrane Database Syst Rev. 2015 Oct 29;(10):CD010693. doi: 10.1002/14651858.CD010693.pub3. Review.

PMID:
26511368
5.
6.

Non-pharmacological interventions for preventing secondary vascular events after stroke or transient ischemic attack.

Mackay-Lyons M, Thornton M, Ruggles T, Che M.

Cochrane Database Syst Rev. 2013 Mar 28;(3):CD008656. doi: 10.1002/14651858.CD008656.pub2. Review.

PMID:
23543566
7.

Secondary prevention lifestyle interventions initiated within 90 days after TIA or 'minor' stroke: a systematic review and meta-analysis of rehabilitation programmes.

Heron N, Kee F, Cardwell C, Tully MA, Donnelly M, Cupples ME.

Br J Gen Pract. 2017 Jan;67(654):e57-e66. doi: 10.3399/bjgp16X688369. Epub 2016 Dec 5. Review.

9.

Vitamin K antagonists versus antiplatelet therapy after transient ischaemic attack or minor ischaemic stroke of presumed arterial origin.

De Schryver EL, Algra A, Kappelle LJ, van Gijn J, Koudstaal PJ.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD001342. doi: 10.1002/14651858.CD001342.pub3. Review.

PMID:
22972051
10.

Triflusal for preventing serious vascular events in people at high risk.

Costa J, Ferro JM, Matias-Guiu J, Alvarez-Sabin J, Torres F.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD004296. Review.

PMID:
16034926
11.

Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.

De Schryver EL, Algra A, van Gijn J.

Cochrane Database Syst Rev. 2003;(1):CD001820. Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD001820.

PMID:
12535415
12.

Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.

Greenhalgh J, Bagust A, Boland A, Martin Saborido C, Oyee J, Blundell M, Dundar Y, Dickson R, Proudlove C, Fisher M.

Health Technol Assess. 2011 Sep;15(31):1-178. doi: 10.3310/hta15310. Review.

13.

Atorvastatin: its clinical role in cerebrovascular prevention.

Gaspardone A, Arca M.

Drugs. 2007;67 Suppl 1:55-62. Review.

PMID:
17910521
14.

Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review.

Lane DA, Raichand S, Moore D, Connock M, Fry-Smith A, Fitzmaurice DA; Steering Committee.

Health Technol Assess. 2013 Jul;17(30):1-188. doi: 10.3310/hta17300. Review.

15.

Interventions for improving modifiable risk factor control in the secondary prevention of stroke.

Lager KE, Mistri AK, Khunti K, Haunton VJ, Sett AK, Wilson AD.

Cochrane Database Syst Rev. 2014 May 2;(5):CD009103. doi: 10.1002/14651858.CD009103.pub2. Review.

PMID:
24789063
16.

Lifestyle interventions for secondary disease prevention in stroke and transient ischaemic attack: a systematic review.

Lennon O, Galvin R, Smith K, Doody C, Blake C.

Eur J Prev Cardiol. 2014 Aug;21(8):1026-39. doi: 10.1177/2047487313481756. Epub 2013 Mar 11. Review.

PMID:
23478741
17.

Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials.

Leonardi-Bee J, Bath PM, Bousser MG, Davalos A, Diener HC, Guiraud-Chaumeil B, Sivenius J, Yatsu F, Dewey ME; Dipyridamole in Stroke Collaboration (DISC).

Stroke. 2005 Jan;36(1):162-8. Epub 2004 Nov 29. Review.

18.

Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.

Algra A, De Schryver EL, van Gijn J, Kappelle LJ, Koudstaal PJ.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD001342. Review. Update in: Cochrane Database Syst Rev. 2012;9:CD001342.

PMID:
16855967
19.

Dual antiplatelet therapy with clopidogrel and aspirin after ischemic stroke: A review of the evidence.

Davis KA, Miyares MA, Dietrich E.

Am J Health Syst Pharm. 2015 Oct 1;72(19):1623-9. doi: 10.2146/ajhp140804. Review.

PMID:
26386103
20.

Supplemental Content

Support Center